- New Site LaunchedWe are proud to announce the launch of our new website. Built on the the university Aurora service, this new version of our site sports a modern look, faster loading times, and works on all mobile and tablet devices.
- Helpful Aurora Guides for New WebmastersTo get started on your new site, take a look on the Aurora site for tips on how to get started.
- Dec 2 Weekly Wednesday Reboot of SAPROD6:30am
Department Of Surgery Teaching Conference Via WebEx7:15am
Wednesday, December 2nd, 2020
07:15 AM - 08:15 AM
Other Live Viewing via WebExDescription to be provided weekly.
Contact Information: Aprile Caulton, 860-679-2290, firstname.lastname@example.orgMore
Dermatology Grand Rounds8:00am
Wednesday, December 2nd, 2020
08:00 AM - 12:00 PM
UConn Health 21 South Road, 2nd Floor“What’s New In Wound Healing For the Dermatologist”
University of Connecticut School of Medicine
Office of Community and Continuing Medical Education and the Department of Dermatology
Speakers: Robert Kirsner, MD – Chairman & Harvey Blank Professor – Dermatology - University of Miami Miller School of Medicine
Date: Wednesday, December 2, 2020
Time: 8am – 9am lecture – Open to All,
9am – 12pm Virtual Patient Viewing and Discussion – Open ONLY to Medical Providers
Location: Dermatology Conference Room, 21 South Road, 2nd Floor, Farmington, CT (Internal Dermatology
Residents, Faculty & Providers ONLY due to UConn COVID-19 policy)
& Video Link for ALL attendees:
Meeting ID: 342 237 7000
Target Audience: UCHC dermatologists and dermatology residents. All other podiatrists, nurses, nurse practitioners, residents, students, and greater Hartford dermatologists are encouraged to attend.
Objectives: Participants will (be able to):
a. Recite the evidence or expert opinion associated with recognizing the latest translational science in wound care.
b. Identify one or more barriers to implementing the evidence or expert opinion in practice proving optimal care of leg ulcers.
c. Describe one or more strategies necessary either to implement the evidence/expert opinion or overcome any barrier to implementation. Incorporate predictive strategies to understand what patients need and when they will need advanced care.
Accreditation: The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Connecticut School of Medicine designates this live educational activity for a maximum of 4 AMA PRA Category 4 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Conflict of Interest Policy: All faculty members participating in CME activities provided by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.
Neither the activity director, planning committee members, nor the speaker - Dr.Kirsner, have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.
Dr. Kirsner will be discussing the investigational use of Beta blockers, ACE Inhibitors, Angiotensin Converting Enzyme, Pentoxifylline, Aspirin, Statins & Deferoxamine.
This CME activity has no commercial suppor
Contact Information: Diane Whitaker-Worth, MD - email@example.comMore
Anti-Human Trafficking Program Evaluation
|Address:||University of Connecticut|
85 Lawler Rd.
West Hartford, CT 06117